01.01.09
Location: UPPER TIBERIAS, ISRAEL
Sales: $90 Million
Description: Key Personnel
Rob Stollar, vice president, global sales and marketing, Ron Broshi, vice president of new product development; John Rank, director of sales and marketing—The Americas, Avi Bash, director sales and marketing, Europe, Russia, Israel, Africa
Plants
Tiberias, Israel; Shamir, Israel; Roxboro, NC
Processes
Hydroentanged Spunlace
ISO Status
ISO 9001:2000 certified
Major Markets
Wipes, Hygiene, Medical, Industrial
New to this year’s report is N.R Spuntech Industries, an Israeli-based manufacturer of spunlace nonwovens with a U.S. operation in Roxboro, NC. Spuntech’s sales have been increasing steadily since opening its U.S. plant in 2006 and from their annual reports sales were approximately $90 million last year.
Founded in 1996, owned by Nissan Medical, Spuntech is traded on the Tel Aviv Stock Exchange . The company has three production facilities and four lines—two in the Galilee, Israel, one in Shamir, Israel and a brand-new site in Roxboro, NC.
The majority of this output targets the hygiene, wet wipes and medical markets where the company works closely with its customers to understand their specific needs and requirements. “We focus on high end products for different markets,” according to director of sales and marketing John Rank. “We are not looking at making just plain vanilla spunlace. We want to provide our customers with innovative products that give them an added advantage in the marketplace.”
Spuntech's spunlace fabrics are comprised of cotton, viscose, polyester, polypropylene or any blend of these fibers, including 100% cotton, 100% viscose or 100% polyester. Fabric-texture options include apertured and a variety of hydro embossed patterns. Spuntech is capable of reaching an extraordinary fabric tensile strength ratio of 1:1.5 to 1:3 MD-CD.
Most of its U.S. output feeds the North and South American markets while Israel primarily serves its local market, Europe and in developing markets such as Russia. “There is room for growth in both regions,” Mr. Rank said. “We are running steady but we are always looking to improve our product mix and bring on new, innovative items.”
Sales: $90 Million
Description: Key Personnel
Rob Stollar, vice president, global sales and marketing, Ron Broshi, vice president of new product development; John Rank, director of sales and marketing—The Americas, Avi Bash, director sales and marketing, Europe, Russia, Israel, Africa
Plants
Tiberias, Israel; Shamir, Israel; Roxboro, NC
Processes
Hydroentanged Spunlace
ISO Status
ISO 9001:2000 certified
Major Markets
Wipes, Hygiene, Medical, Industrial
New to this year’s report is N.R Spuntech Industries, an Israeli-based manufacturer of spunlace nonwovens with a U.S. operation in Roxboro, NC. Spuntech’s sales have been increasing steadily since opening its U.S. plant in 2006 and from their annual reports sales were approximately $90 million last year.
Founded in 1996, owned by Nissan Medical, Spuntech is traded on the Tel Aviv Stock Exchange . The company has three production facilities and four lines—two in the Galilee, Israel, one in Shamir, Israel and a brand-new site in Roxboro, NC.
The majority of this output targets the hygiene, wet wipes and medical markets where the company works closely with its customers to understand their specific needs and requirements. “We focus on high end products for different markets,” according to director of sales and marketing John Rank. “We are not looking at making just plain vanilla spunlace. We want to provide our customers with innovative products that give them an added advantage in the marketplace.”
Spuntech's spunlace fabrics are comprised of cotton, viscose, polyester, polypropylene or any blend of these fibers, including 100% cotton, 100% viscose or 100% polyester. Fabric-texture options include apertured and a variety of hydro embossed patterns. Spuntech is capable of reaching an extraordinary fabric tensile strength ratio of 1:1.5 to 1:3 MD-CD.
Most of its U.S. output feeds the North and South American markets while Israel primarily serves its local market, Europe and in developing markets such as Russia. “There is room for growth in both regions,” Mr. Rank said. “We are running steady but we are always looking to improve our product mix and bring on new, innovative items.”